Literature DB >> 16456231

Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.

Matthijs J Faber1, Giulio Agnetti, Karel Bezstarosti, Inge M Lankhuizen, Michiel Dalinghaus, Carlo Guarnieri, Claudio M Caldarera, Willem A Helbing, Jos M J Lamers.   

Abstract

The key components to the molecular understanding of the pathophysiology of various forms of heart failure involve global and/or large-scale identifications of proteins, their patterns of expression, posttranslational modifications, and functional characterization. Particularly, proteins involved in the induction of cardiac (mal)adaptive hypertrophic growth, interstitial fibrosis, and contractile dysfunction are of interest. In general, with the accumulation of vast amounts of DNA sequences in databases, researchers have become aware that merely having complete sequences of genomes and transcriptional changes for thousands of genes simultaneously will not be sufficient to elucidate, in molecular terms, the etiology and pathophysiology of cardiovascular disease. In the last decade, a new technology called proteomics has become available that allows biological and (patho)physiological questions to be approached exclusively from the protein perspective. Proteomics may enable us to map the entire complement of proteins expressed by the heart at any time and condition. This approach creates the unique possibility to identify, by differential analysis, protein alterations associated with the etiology of heart disease and its progression, outcome, and response to therapy. To illustrate the true power of proteomics, most of the currently available methodologies are first reviewed, including their limitations. This review also deals with the current status and the perspectives of proteomics applications in research on heart failure in general. Furthermore, examples of our recent data on global protein profiling of the pressure-overloaded rat right ventricle and of endothelin-1-stimulated cultures of neonatal rat cardiac myocytes are provided. The last section is devoted to the continuous advances in proteomic technologies, including protein separation methods, mass spectrometric instrumentation, computational analysis, and bioinformatic tools, together with integrative databases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456231     DOI: 10.1385/CBB:44:1:011

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  9 in total

Review 1.  Proteomic technologies in the study of kinases: novel tools for the investigation of PKC in the heart.

Authors:  G Agnetti; L A Kane; C Guarnieri; C M Caldarera; J E Van Eyk
Journal:  Pharmacol Res       Date:  2007-05-03       Impact factor: 7.658

2.  Peptide Shifter: enhancing separation reproducibility using correlated expression profiles.

Authors:  Dmitri Sitnikov; Joanna M Hunter; Clive Hayward; Kevin Eng; Isabelle Migneault; Sylvain Tessier; Gregory J Opiteck; Paul Kearney
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-19       Impact factor: 3.109

3.  Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes.

Authors:  Lianna Li; Joel R Sevinsky; Megan D Rowland; Jonathan L Bundy; James L Stephenson; Barbara Sherry
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

Review 4.  Divide and conquer: the application of organelle proteomics to heart failure.

Authors:  Giulio Agnetti; Cathrine Husberg; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2011-02-18       Impact factor: 17.367

5.  Proteomic profiling of human sera for discovery of potential biomarkers to monitor abstinence from alcohol abuse.

Authors:  Xianyin Lai; Suthat Liangpunsakul; Kaigang Li; Frank A Witzmann
Journal:  Electrophoresis       Date:  2015-01-22       Impact factor: 3.535

6.  Proteomic profiling of endothelin-1-stimulated hypertrophic cardiomyocytes reveals the increase of four different desmin species and alpha-B-crystallin.

Authors:  Giulio Agnetti; Karel Bezstarosti; Dick H W Dekkers; Adrie J M Verhoeven; Emanuele Giordano; Carlo Guarnieri; Claudio M Caldarera; Jennifer E Van Eyk; Jos M J Lamers
Journal:  Biochim Biophys Acta       Date:  2008-04-18

7.  A proteomic workflow for discovery of serum carrier protein-bound biomarker candidates of alcohol abuse using LC-MS/MS.

Authors:  Xianyin Lai; Suthat Liangpunsakul; David W Crabb; Heather N Ringham; Frank A Witzmann
Journal:  Electrophoresis       Date:  2009-06       Impact factor: 3.535

8.  Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol.

Authors:  Karel Bezstarosti; Samarjit Das; Jos M J Lamers; Dipak K Das
Journal:  J Cell Mol Med       Date:  2006 Oct-Dec       Impact factor: 5.310

9.  Molecular Mechanism of HSF1-Upregulated ALDH2 by PKC in Ameliorating Pressure Overload-Induced Heart Failure in Mice.

Authors:  Endong Ji; Tiantian Jiao; Yunli Shen; Yunjia Xu; Yuanqing Sun; Zichun Cai; Qi Zhang; Jiming Li
Journal:  Biomed Res Int       Date:  2020-06-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.